Perloff M, Holland J F
Annu Rev Med. 1977;28:475-88. doi: 10.1146/annurev.me.28.020177.002355.
The evidence that the principles of surgical adjuvant chemotherapy developed in experimental animal systems also apply to a variety of neoplastic diseases in man has been clearly demonstrated. Micrometastatic disease can be eradicated with effective chemotherapy in several diseases. Prolongation of disease-free interval, if not cure, is now possible in diseases in which curative surgery alone or in combination with radiotherapy does not achieve these goals. The previously fatal childhood solid tumors--Wilms', Ewings' sarcoma, embryonal rhabdomyosarcoma--are curable in a high percentage of patients appropriately treated with combinations of surgery, radiotherapy, and chemotherapy. The prolongation of the disease-free interval in osteogenic sarcoma has permitted consideration of entirely new surgical approaches for this tumor in which radical amputation has traditionally been employed. The spectacular results achieved in the treatment of Stage II breast cancer may potentially save hundreds of thousands of lives in the coming decade. Clinically recognizable metastatic disease is rarely curable by any currently available treatment modality. The prolongation of disease-free intervals and production of cures when surgical adjuvant chemotherapy is employed may be partly explained by relatively more circulation, and thus drug delivery to each tumor cell, more favorable cellular kinetics, and a healthier and more immunocompetent host who is better able to withstand drug effects on normal tissues, and to participate in tumor destruction. Cures of certain patients with neoplastic diseases using surgical adjuvant chemotherapy has increased the incentive to learn more about new and old drugs and their effective use alone and in combination. Chemotherapy, in appropriate combinations with surgery, radiotherapy, and immunotherapy, may well be more efficacious in many clinical situations than the traditional use of single-modality treatment. The data presented in this paper relate solid evidence that the possibility of cure in a variety of neoplastic diseases is real.
在实验动物系统中制定的手术辅助化疗原则也适用于人类多种肿瘤疾病,这一点已有明确证据。在几种疾病中,有效的化疗可根除微转移疾病。对于单独进行根治性手术或联合放疗无法实现治愈目标的疾病,现在延长无病生存期(即便不是治愈)已成为可能。以前致命的儿童实体瘤——肾母细胞瘤、尤因肉瘤、胚胎性横纹肌肉瘤——通过手术、放疗和化疗联合进行适当治疗,很大比例的患者可以治愈。骨肉瘤无病生存期的延长使得人们可以考虑针对这种传统上采用根治性截肢手术的肿瘤采用全新的手术方法。在II期乳腺癌治疗中取得的显著成果可能在未来十年挽救数十万生命。目前任何可用的治疗方式都很少能治愈临床上可识别的转移性疾病。采用手术辅助化疗时无病生存期的延长和治愈情况的出现,部分原因可能是相对更多的循环,从而使药物能够输送到每个肿瘤细胞,更有利的细胞动力学,以及更健康、免疫功能更强的宿主,这样的宿主更能承受药物对正常组织的影响,并参与肿瘤破坏。使用手术辅助化疗治愈某些肿瘤疾病患者,增加了人们进一步了解新旧药物及其单独和联合有效使用方法的动力。化疗与手术、放疗和免疫疗法适当联合,在许多临床情况下可能比传统的单一治疗方式更有效。本文提供的数据确凿地证明,多种肿瘤疾病实现治愈的可能性是真实存在的。